The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients

J. Hans DeVries, Alar Irs, Hans L. Hillege

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)3492-3494
Number of pages3
JournalEuropean Heart journal
Volume44
Issue number37
DOIs
Publication statusPublished - 1 Oct 2023

Cite this